Evidence map›Paper›PMID 34458596›Full record

ArticleBiochemistry and biophysics reports2021

Identification of canine circulating miRNAs as tumor biospecific markers using Next-Generation Sequencing and Q-RT-PCR.

Payal Agarwal, Melissa P Crepps, Natalie A Stahr, Will P Kretzschmar, Hannah C Harris, Nripesh Prasad, Shawn E Levy, Bruce F Smith

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. The role of epigenetic alterations in canine mammary cancer.The Journal of reproduction and development · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas.International journal of molecular sciences · 2023
    Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Payal AgarwalScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, USA.
Melissa P CreppsScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, USA.
Natalie A StahrScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, USA.
Will P KretzschmarScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, USA.
Hannah C HarrisScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, USA.
Nripesh PrasadHudsonAlpha Discovery Life Science, Huntsville, AL 35806, USA.
Shawn E LevyHudsonAlpha Discovery Life Science, Huntsville, AL 35806, USA.
Bruce F SmithScott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, USA.
Auburn University · USHudsonAlpha Institute for Biotechnology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Delay in cancer diagnosis often results in metastasis and an inability to successfully treat the tumor. The use of broadly cancer-specific biomarkers at an early stage may improve cancer treatment and staging. This study has explored circulatory exosomal miRNAs as potential diagnostic biomarkers to identify cancer patients. Secretory exosomal miRNAs were isolated from 13 canine cancer cell lines (lymphoma, mast cell tumor, histiocytic cell line, osteosarcoma, melanoma, and breast tumor) and were sequenced by Next-Generation sequencing (NGS). We have identified 6 miRNAs (cfa-miR-9, -1841, -1306, -345, -132, and -26b) by NGS that were elevated in all cancer cell types. The miRNAs identified by NGS were then examined by Q-RT-PCR. The PCR data demonstrated similar expression patterns to those seen with NGS but provided fold differences that were much lower than those seen for NGS. Cfa-miR-9 was found to be the most consistently elevated miRNA in NGS and PCR, making it the most likely miRNA to prove diagnostic. In this study, we have demonstrated that it is possible to identify exosomal miRNAs with elevated secretion across multiple tumor types that could be used as circulatory diagnostic biomarkers for liquid biopsy in the future.

Indexed as

CancerCirculatory miRNAsDiagnostic biomarkerDogNext-generation sequencing

Identifiers

PMID34458596
PMCPMC8379617
OpenAlexW3194445563

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.